Network for network concept offers new insights into host-SARS-CoV-2 protein interactions and potential novel targets for developing antiviral drugs
Abstract SARS-CoV-2, the causal agent of COVID-19, is primarily a pulmonary virus that can
directly or indirectly infect several organs. Despite many studies carried out during the …
directly or indirectly infect several organs. Despite many studies carried out during the …
Determining SARS-CoV-2 non-infectivity state–A brief overview
SF Brynjolfsson, H Sigurgrimsdottir… - Frontiers in Public …, 2022 - frontiersin.org
From the beginning of the COVID-19 pandemic, it has claimed over 6 million lives, and
globally the pandemic rages with detrimental consequences, with the emergence of new …
globally the pandemic rages with detrimental consequences, with the emergence of new …
VIPERA: Viral Intra-Patient Evolution Reporting and Analysis
M Álvarez-Herrera, J Sevilla, P Ruiz-Rodriguez… - Virus …, 2024 - academic.oup.com
Viral mutations within patients nurture the adaptive potential of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) during chronic infections, which are a potential …
syndrome coronavirus 2 (SARS-CoV-2) during chronic infections, which are a potential …